{"id":203022,"name":"RARE ACCESS ACTION PROJECT","slug":"rare-access-action-project","state":"VA","country":"United States of America","description":"reimbursement for rare disease patient care","totalSpending":552000,"filings":30,"yearlySpending":[{"year":2018,"income":0},{"year":2019,"income":0},{"year":2020,"income":48000},{"year":2021,"income":48000},{"year":2022,"income":48000},{"year":2023,"income":120000},{"year":2024,"income":144000},{"year":2025,"income":144000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"MMM","display":"Medicare/Medicaid"},{"code":"MED","display":"Medical/Disease Research/Clinical Labs"}],"firms":["COMMONWEALTH POLICY SOLUTIONS"],"lobbyists":["MICHAEL EGING"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["reimbursement for rare disease patient care","reimbursement for rare disease patient care","reimbursement for rare disease patient care","Reimbursement for rare disease patient care","Reimbursement for rare disease patient care"]}